NCT04219397

Brief Summary

The overall objective of this study is to evaluate strategies to reduce unused opioids prescribed for pediatric acute post-surgical pain management.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
83

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2019

Completed
25 days until next milestone

First Posted

Study publicly available on registry

January 7, 2020

Completed
16 days until next milestone

Study Start

First participant enrolled

January 23, 2020

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 3, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 3, 2023

Completed
Last Updated

February 15, 2024

Status Verified

February 1, 2024

Enrollment Period

2.9 years

First QC Date

December 13, 2019

Last Update Submit

February 14, 2024

Conditions

Keywords

opioid stewardship

Outcome Measures

Primary Outcomes (3)

  • Quantification of residual opioids.

    Identify if there are left over opioid medications following completion of analgesic therapy, and if so, how many?

    Post-discharge days 8-10

  • Assess participation in medication take back through follow up phone interview questionnaire.

    Assess the degree of participation in medication take back programs to dispose of any residual opioid medications following completion of analgesic therapy.

    Post-discharge days 8-10

  • Assess participation in medication home disposal through follow up phone interview questionnaire.

    Assess the degree of participation in medication home disposal to dispose of any residual opioid medications following completion of analgesic therapy.

    Post-discharge days 8-10

Secondary Outcomes (3)

  • Identify noncompliance/unsafe behaviors that contribute to retention of residual opioids through follow up phone interview questionnaire.

    Post-discharge days 8-10

  • Average daily pain scores reported as values on Numerical Rating Scale.

    Preoperatively through post-discharge day #10

  • Frequency of opioid consumption through follow up phone interview questionnaire.

    Post-operative day 1 through post-discharge day 10

Other Outcomes (8)

  • Demographic data

    preoperatively through post-discharge day 10

  • Post operative pain scores reported as a numerical value on the Numerical Rating Scale.

    Post operative day zero through post-discharge day 10

  • Opioid consumption

    Preoperatively through post-discharge day 10

  • +5 more other outcomes

Study Arms (3)

Control

NO INTERVENTION

Patients in this group will receive usual care from the acute pain medicine service, and will go home with standardized multimodal analgesic protocol. There will be no interventions provided. They will receive a follow up phone call survey and be asked to return a completed medication education calendar that is provided as a part of usual APS care.

Medication take back education intervention

EXPERIMENTAL

Patients in this group will receive usual care from the acute pain medicine service, and will go home with standardized multimodal analgesic protocol as described in the control group. They will receive a standardized education intervention. This intervention will educate patients and their families about medication take back programs, and will provide tailored directions to the closest medication take back center from their home, and also an option for medication take back that is located in close proximity to Riley Hospital clinics.

Other: Medication take back

Home disposal kit intervention

EXPERIMENTAL

Patients in this group will receive usual care from the acute pain medicine service, and will go home with standardized multimodal analgesic protocol as described in the control group. They will receive standardized education about how to use the medication home disposal kit : Dispose Rx(r), and they will be instructed to use this kit to dispose of any left over opioid medications that they may have after they have competed therapy for pain management at home.

Other: Medication home disposal

Interventions

Patients will be provided with formal education about medication take back programs for left-over prescription medications. They will be provided with directions to the closest medication take back facility to their home, and directions to the closet medication take back facility near their post-operative clinic site, and instructed to dispose of any left-over oxycodone medication (at completion of analgesic therapy) through participating in medication take back.

Medication take back education intervention

Patients and their families will be provided with formal education about how to use the medication home disposal kit: Dispose Rx, provided with a Dispose Rx home disposal kit, and instructed to dispose of any left-over oxycodone prescription medications with this kit following completion of analgesic therapy.

Home disposal kit intervention

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Male or female children ages 12-17.9 years old
  • ASA physical status 1 and 2
  • Patients undergoing primary posterior spinal fusion surgery for correction of idiopathic scoliosis.
  • Patients undergoing Nuss bar correction of pectus excavatum deformity.

You may not qualify if:

  • Oxycodone allergy
  • severe sleep apnea
  • developmental delay
  • neurological disorders
  • liver disease/impairment
  • renal disease/decreased renal function
  • patients on opioid therapy prior to surgery
  • Requires a translator for communication in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Riley Hospital for Children/Indiana University

Indianapolis, Indiana, 46202, United States

Location

Children's Hospital of New Orleans/ LCMC Health

New Orleans, Louisiana, 70118, United States

Location

Study Officials

  • Michele A Hendrickson, MD,MS

    Indiana University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Following patient enrollment, only the unblinded study coordinators will provide information and education to the patients/families about which arm they are randomized to. The investigator and other collaborators will conduct follow-up phone calls and data input and analysis in a blinded fashion.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: 1. Usual care (control) 2. Intervention #1: provision of formal education on medication take back 3. Intervention #2: provision of formal education on medication home disposal of residual opioids, and provision of a medication home disposal kit.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 13, 2019

First Posted

January 7, 2020

Study Start

January 23, 2020

Primary Completion

January 3, 2023

Study Completion

January 3, 2023

Last Updated

February 15, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations